SCHEMBL691293

SCHEMBL691293

C1CCC2(CC1)CO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712408 1.00
SCHEMBL2209773 1.00
SCHEMBL4569054 1.00
SCHEMBL1067654 0.96
SCHEMBL2112718 0.88
SCHEMBL5612531 0.83
SCHEMBL5612536 0.83
SCHEMBL5612528 0.83
SCHEMBL15568524 0.81
SCHEMBL11302156 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114539448-B Catalyst for olefin polymerization and preparation method and application thereof 北京吉海川科技发展有限公司 2024-02-27 CN claimed
US-11710854-B2 Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries ENEVATE CORPORATION (US) 2023-07-25 US claimed
WO-2022093797-A1 FUNCTIONAL EPOXIDES IN CATALYST-BASED ELECTROLYTE COMPOSITIONS FOR LI-ION BATTERIES ENEVATE CORPORATION (US) 2022-05-05 WO claimed
US-20220140392-A1 FUNCTIONAL EPOXIDES IN CATALYST-BASED ELECTROLYTE COMPOSITIONS FOR LI-ION BATTERIES ENEVATE CORPORATION 2022-05-05 US claimed
US-20190127522-A1 HIGH GLASS TRANSITION TEMPERATURE POLYCARBONATES DERIVED FROM ADAMANTANE EPOXIDES PROMERUS, LLC (US) 2019-05-02 US claimed
EP-1480964-A1 INHIBITEURS DE L'ANGIOGENESE Galderma Research & Development, S.N.C. (FR) 2004-12-01 EP claimed
US-20030134896-A1 Novel angiogenesis inhibitors and pharmaceutical and cosmetic use thereof GALDERMA RESEARCH & DEVELOPMENT (FR) 2003-07-17 US claimed
WO-2003040119-A1 ANGIOGENESIS INHIBITORS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2003-05-15 WO claimed
EP-0729380-B1 HYDROPHILIC COMPOSITIONS WITH INCREASED THERMAL RESISTANCE GORE & ASS (US) 1998-07-08 EP claimed
EP-0729380-A1 HYDROPHILIC COMPOSITIONS WITH INCREASED THERMAL RESISTANCE W.L. GORE & ASSOCIATES, INC. (US) 1996-09-04 EP claimed
WO-1995013859-A1 HYDROPHILIC COMPOSITIONS WITH INCREASED THERMAL RESISTANCE W.L. GORE & ASSOCIATES, INC. (US) 1995-05-26 WO claimed
EP-0354787-B1 Oxaspiro[2,5]octane derivative FUJISAWA PHARMACEUTICAL CO (JP) 1995-02-15 EP claimed
US-5352511-A Copolymer of fluorinated ethylenically unsaturated monomer and vinyl alcohol reacted with a monoepoxide W. L. GORE & ASSOCIATES, ONC. (US) 1994-10-04 US claimed
EP-0354787-A1 Oxaspiro[2,5]octane derivative FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-14 EP claimed
EP-3881048-B1 DEVICE FOR REMOVING VOLATILE ORGANIC COMPOUNDS LETAT FRANCAIS REPRESENTE PAR LE MINI DE LINTERIEUR (FR) 2026-05-06 EP disclosed
EP-4720055-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF Arcus Biosciences, Inc. (US) 2026-04-08 EP disclosed
US-12540157-B2 Oxysterols and methods of use thereof Sage Therapeutics, LLC (US) 2026-02-03 US disclosed
EP-0354787-A1 Oxaspiro[2,5]octane derivative FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-14 EP disclosed
US-4876367-A ANIMAL GROWTH REGULATORS PFIZER INC. (US) 1989-10-24 US disclosed
US-4777270-A INCREASE EFFICIENCY OF FEED UTILIZATION IN RUMINANTS PFIZER INC. (US) 1988-10-11 US disclosed